Free Trial
→ Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (From Brownstone Research) (Ad)

10 Best Penny Stocks to Buy Now - 9 of 10

Slide 9
Back to 8
Continue to 10
 
Back to 8
Continue to 10
 

Context Therapeutics (NASDAQ:CNTX)

Number of Upgrades from Top-Ranked Analysts
3 (in the last 90 days)
Consensus Rating
Buy
Rating Score
3.0
Ratings Breakdown
5 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$6.80 (580.0% Upside)

About Context Therapeutics

Context Therapeutics logoContext Therapeutics Inc, a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
11/25/2024D. Boral CapitalInitiated CoverageBuy$9.00
9/23/2024HC WainwrightReiterated RatingBuy ➝ Buy$6.00 ➝ $6.00
9/16/2024HC WainwrightReiterated RatingBuy ➝ Buy$6.00 ➝ $6.00
7/10/2024HC WainwrightReiterated RatingBuy ➝ Buy$5.00 ➝ $5.00
5/16/2024Piper SandlerInitiated CoverageOverweight$4.50
5/16/2024Piper Sandler CompaniesInitiated CoverageOverweight$4.50
5/9/2024HC WainwrightBoost Price TargetBuy ➝ Buy$4.00 ➝ $5.00
5/9/2024Maxim GroupBoost Price TargetBuy ➝ Buy$4.00 ➝ $10.00
3/21/2024HC WainwrightLower Price TargetBuy ➝ Buy$5.00 ➝ $4.00
11/1/2023HC WainwrightUpgradeNeutral ➝ Buy$5.00
Slide 9
Back to 8
Continue to 10
 

How Low-Cost Stocks Generate Monthly Income (Ad)

Are you ready to transform your investment strategy and generate a steady monthly income? We’re excited to offer you our exclusive report, "Options Trading Strategy: 2 (Surprisingly) Low-Cost Stocks Primed for Generating Monthly Income," FREE!

👉 Yes, I Want the Free Report! 👈

More From MarketBeat
Amazon coin set to soar 25X – starting December 16th?
This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...
True Market Insiders | Sponsored
7 Gene Editing Stocks Offering Transformational Change
Investors are talking about the impact that artificial intelligence (AI) can have on their portfolios. But the...
MarketBeat
Did You See Trump’s Bombshell Exec. Order 001?
Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."
Banyan Hill Publishing | Sponsored
7 Artificial Intelligence Stocks That Are Still Long-Term Winners
It's hard to believe that two years ago, many of us had never heard of ChatGPT. But for the last 18 months, in...
MarketBeat
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
7 Alcohol Stocks Primed to Pour Profits
In 2020 and 2021, alcohol stocks were among the best-performing consumer staples stocks. But it's been a diffe...
MarketBeat